MetaVia (MTVA) Current Assets (2015 - 2026)
MetaVia's (MTVA) quarterly Current Assets came in at $10.9 million in Q4 2025, down 32.34% YoY from $16.1 million in Q4 2024, and down 25.75% on a QoQ basis from $14.6 million in Q3 2025.
MetaVia (MTVA) Current Assets (2015 - 2026) Analysis & Trends
MetaVia (MTVA) has 11 years of Current Assets data on file, last reported at $10.9 million in Q4 2025.
- Quarterly Current Assets fell 32.34% year-over-year to $10.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $10.9 million (down 32.34% YoY) and the FY2025 annual result came in at $10.9 million, down 32.34% from the prior year.
- Current Assets declined to $10.9 million in Q4 2025, from $14.6 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $33.5 million in Q4 2022 to a low of $7.6 million in Q3 2022.
- A 5-year average of $18.1 million and a median of $16.3 million in 2021 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2023 — Current Assets jumped 246.11% — and 2024, when it tumbled 46.75%.
- Tracing MTVA's Current Assets over 5 years: stood at $16.6 million in 2021, then surged by 102.19% to $33.5 million in 2022, then plunged by 32.86% to $22.5 million in 2023, then decreased by 28.61% to $16.1 million in 2024, then tumbled by 32.34% to $10.9 million in 2025.
- The last three Current Assets figures came in at $10.9 million (Q4 2025), $14.6 million (Q3 2025), and $18.3 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.76 Bn |
| 10 | MetaVia | 8.72 Mn | -3.92 Mn | - | 13.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.07 Mn |
| Dec 31, 2025 | 10.88 Mn |
| Sep 30, 2025 | 14.65 Mn |
| Jun 30, 2025 | 18.32 Mn |
| Mar 31, 2025 | 11.96 Mn |
| Dec 31, 2024 | 16.07 Mn |
| Sep 30, 2024 | 21.94 Mn |
| Jun 30, 2024 | 28.52 Mn |
| Mar 31, 2024 | 16.76 Mn |
| Dec 31, 2023 | 22.51 Mn |
| Sep 30, 2023 | 26.15 Mn |
| Jun 30, 2023 | 29.17 Mn |
| Mar 31, 2023 | 31.48 Mn |
| Dec 31, 2022 | 33.53 Mn |
| Sep 30, 2022 | 7.55 Mn |
| Jun 30, 2022 | 10.08 Mn |
| Mar 31, 2022 | 13.26 Mn |
| Dec 31, 2021 | 16.58 Mn |
| Sep 30, 2021 | 7.84 Mn |
| Jun 30, 2021 | 10.47 Mn |